Toxic effects, bioconcentration and depuration of verapamil in the early life stages of common carp (Cyprinus carpio L.)

Science of the Total Environment

Volumn 461-462, Issue , 2013, Pages 198-206

  Steinbach, Christoph ^a   Fedorova, Ganna ^a   Prokes, Miroslav ^b   Grabicova, Katerina ^a   Machova, Jana ^a   Grabic, Roman ^a   Valentova, Olga ^a   Kroupova, Hana Kocour ^a  

^a UNIVERSITY OF SOUTH BOHEMIA   (Czech Republic)

^b INSTITUTE OF VERTEBRATE BIOLOGY   (Czech Republic)

Author keywords

Bioconcentration; Embryo larval test; Half life time; Heart rate; Verapamil

Indexed keywords

BIOCONCENTRATION; EMBRYO-LARVAL TEST; HALF-LIFE TIME; HEART RATES; VERAPAMIL;

BIOACCUMULATION; BIOHAZARDS; FISH; HEART; INDUSTRIAL POISONS;

BIOMARKERS;

VERAPAMIL;

BIOACCUMULATION; CONCENTRATION (COMPOSITION); CYPRINID; DEPURATION; DEVELOPMENTAL STAGE; DRUG; POLLUTION EFFECT; POLLUTION EXPOSURE; TOXICITY TEST;

ACUTE TOXICITY; ANIMAL EMBRYO; ANIMAL TISSUE; ARTICLE; BIOACCUMULATION; CARP; CHRONIC TOXICITY; CONCENTRATION (PARAMETERS); CONGENITAL MALFORMATION; CONTROLLED STUDY; DEATH; DEPURATION; DEVELOPMENTAL STAGE; DEVELOPMENTAL TOXICITY; EDEMA; EMBRYO; ENVIRONMENTAL EXPOSURE; HALF LIFE TIME; HEART RATE; HOMOGENATE; LARVA; LIFE CYCLE STAGE; NONHUMAN; PRIORITY JOURNAL; PROCEDURES; TOXICITY TESTING;

BIOCONCENTRATION; EMBRYO-LARVAL TEST; HALF-LIFE TIME; HEART RATE; VERAPAMIL;

AGE FACTORS; ANALYSIS OF VARIANCE; ANIMALS; CARPS; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG RESIDUES; EMBRYO, NONMAMMALIAN; HALF-LIFE; HEART RATE; LARVA; LETHAL DOSE 50; TIME FACTORS; TOXICITY TESTS, ACUTE; VERAPAMIL;

ANGINA; CYPRINIDAE; CYPRINUS CARPIO;

EID: 84878459123     PISSN: 00489697     EISSN: 18791026     Source Type: Journal    
DOI: 10.1016/j.scitotenv.2013.05.002     Document Type: Article

References (58)

1. Alderton W., Berghmans S., Butler P., Chassaing H., Fleming A., Golder Z., et al. Accumulation and metabolism of drugs and CYP probe substrates in zebrafish larvae. Xenobiotica 2010, 40:547-557.
2. Batt A.L., Kostich M.S., Lazorchak J.M. Analysis of ecologically relevant pharmaceuticals in wastewater and surface water using selective solid-phase extraction and UPLC-MS/MS. Anal Chem 2008, 80:5021-5030.
3. Berghmans S., Butler P., Goldsmith P., Waldron G., Gardner I., Golder Z., et al. Zebrafish based assays for the assessment of cardiac, visual and gut function - potential safety screens for early drug discovery. J Pharmacol Toxicol Methods 2008, 58:59-68.
4. Burgess A., Vere D.W. Teratogenic effects of some calcium channel blocking agents in Xenopus embryos. Pharmacol Toxicol 1989, 64:78-82.
5. Burkina V., Zamaratskaia G., Randak T., Li Z.H., Fedorova G., Pickova J., et al. Verapamil does not modify catalytic activity of CYP450 in rainbow trout after long-term exposure. Ecotoxicol Environ Saf 2012, 79:148-152.
6. Cook J.T., McNiven M.A., Richardson G.F., Sutterlin A.M. Growth rate, body composition and feed digestibility/conversion of growth-enhanced transgenic Atlantic salmon (Salmo salar). Aquaculture 2000, 188:15-32.
7. Corcoran J., Winter M.J., Tyler C.R. Pharmaceuticals in the aquatic environment: a critical review of the evidence for health effects in fish. Crit Rev Toxicol 2010, 40:287-304.
8. Drenth J.F., Michiels J.J., Van Joost T., Vuzevski V.D. Verapamil-induced secondary erythermalgia. Br J Dermatol 1992, 127:292-294.
9. Eichelbaum M., Mirkus G., Vogelgesang B. Pharmacokinetics of (+)-, (-)- and (+-)-verapamil after intravenous administration. Br. J. clin. Pharmac. 1984, 17:453-458.
10. Fent K., Weston A.A., Caminada D. Ecotoxicology of human pharmaceuticals. Aquat Toxicol 2006, 76:122-159.
11. Fick J., Lindberg R.H., Tysklind M., Larsson D.G. Predicted critical environmental concentrations for 500 pharmaceuticals. Regul Toxicol Pharmacol 2010, 58:516-523.
12. Fick J., Lindberg R.H., Parkkonen J., Arvidsson B., Tysklind M., Larsson D.G.J. Therapeutic levels of levonorgestrel detected in blood plasma of fish: results from screening rainbow trout exposed to treated sewage effluents. Environ Sci Technol 2010, 44:2661-2666.
13. Franke C. How meaningful is the bioconcentration factor for risk assessment?. Chemosphere 1996, 32:1897-1905.
14. Gomez C.F., Constantine L., Huggett D.B. The influence of gill and liver metabolism on the predicted bioconcentration of three pharmaceuticals in fish. Chemosphere 2010, 81:1189-1195.
15. Grossman E., Messerli F.H. Calcium antagonists. Prog Cardiovasc Dis 2004, 47:34-57.
16. Gunnarsson L., Jauhiainen A., Kristiansson E., Nerman O., Larsson D.G.J. Evolutionary conservation of human drug targets in organisms used for environmental risk assessments. Environ Sci Technol 2008, 42:5807-5813.
17. Huggett D.B., Cook J.C., Ericson J.F., Williams R.T. A theoretical model forutilizing mammalian pharmacology and safety data to prioritize potentialimpacts of human pharmaceuticals to fish. Hum. Ecol. Risk Assess. 2003, 9:1789-1799.
18. Hummel D., Löffler D., Fink G., Ternes T.A. Simultaneous determination of psychoactive drugs and their metabolites in aqueous matrices by liquid chromatography mass spectrometry. Environ Sci Technol 2006, 40:7321-7328.
19. Jezierska B., Lugowska K., Witeska M., Sarnowski P. Malformations of newly hatched common carp larvae. Electron J Pol Agric Univ 2000, 3.
20. Johnston A., Burgess C.D., Hamer J. Systemic availability of oral verapamil and effect on PR interval in man. Br J Clin Pharmacol 1981, 12:397-400.
21. Khan S.J., Ongerth J.E. Modelling of pharmaceutical residues in Australian sewage by quantities of use and fugacity calculations. Chemosphere 2004, 54:355-367.
22. Khetan S.K., Collins T.J. Human pharmaceuticals in the aquatic environment: a challenge to green chemistry. Chem Rev 2007, 107:2319-2364.
23. Kocour M., Gela D., Rodina M., Linhart O. Testing of performance in common carp Cyprinus carpio L. under pond husbandry conditions I: top-crossing with Northern mirror carp. Aquacult Res 2005, 36:1207-1215.
24. Kristoffersen J.B., Salvanes A.G.V. Effects of formaldehyde and ethanol preservation on body and otoliths of Maurolicus muelleri and Benthosema glaciale. Sarsia 1998, 83:95-102.
25. Kroupova H., Prokes M., Macova S., Penaz M., Barus V., Novotny L., et al. Effect of nitrite on early-life stages of common carp (Cyprinus carpio L.). Environ Toxicol Chem 2010, 29:535-540.
26. Kvarnryd M., Grabic R., Brandt I., Berg C. Early life progestin exposure causes arrested oocyte development, oviductal agenesis and sterility in adult Xenopus tropicalis frogs. Aquat Toxicol (Amst Neth) 2011, 103:18-24.
27. Lacinova L., Welling A., Bosse E., Ruth P., Flockerzi V., Hofmann F. Interaction of Ro 40-5967 and verapamil with the stably expressed alpha 1-subunit of the cardiac L-type calcium channel. J Pharmacol Exp Ther 1995, 274:54-63.
28. Li Z.H., Li P., Randak T. Ecotoxocological effects of short-term exposure to a human pharmaceutical verapamil in juvenile rainbow trout (Oncorhynchus mykiss). Comp Biochem Physiol C: Toxicol Pharmacol 2010, 152:385-391.
29. Li Z.H., Velisek J., Zlabek V., Grabic R., Machova J., Kolarova J., et al. Chronic toxicity of Verapamil on juvenile rainbow trout (Oncorhynchus mykiss): effects on morphological indices; hematological parameters and antioxidant responses. J Hazard Mater 2010, 185:870-880.
30. Lüllmann H., Mohr K., Wehling M. Pharmakologie und Toxikologie: Thieme, Stuttgart,15. komplett überarbeitete Auflage 2003, [32, 115].
31. Luurtsema G., Molthoff C.F.M., Schuit R.C., Windhorst A.D., Lammertsma A.A., Franssen E.J.F. Evaluation of (R)-[11C]verapamil as PET tracer of P-glycoprotein function in the blood-brain barrier: kinetics and metabolism in the rat. Nucl Med Biol 2005, 32:87-93.
32. Machova J., Prokeš M., Kroupová H., Svobodová Z., Mácová S., Doleželová P., et al. Early ontogeny, growth and mortality of common carp (Cyprinus carpio) at low concentrations of dimethyl sulfoxide. Acta Vet Brno 2009, 78:505-512.
33. Mackay D., Fraser A. Bioaccumulation of persistent organic chemicals: mechanisms and models. Environ Pollut 2000, 110:375-391.
34. Mehinto A.C., Hill E.M., Tyler C.R. Uptake and biological effects of environmentally relevant concentrations of the nonsteroidal anti-inflammatory pharmaceutical diclofenac in rainbow trout (Oncorhynchus mykiss). Environ Sci Technol 2010, 44:2176-2182.
35. Nallani G.C., Paulos P.M., Constantine L.A., Venables B.J., Huggett D.B. Bioconcentration of ibuprofen in fathead minnow (Pimephales promelas) and channel catfish (Ictalurus punctatus). Chemosphere 2011, 84:1371-1377.
36. Nash J.P., Kime D.E., Van der Ven L.T.M., Wester P.W., Brion F., Maack G., et al. Long-term exposure to environmental concentrations of the pharmaceutical ethynylestradiol causes reproductive failure in fish. Environ Health Perspect 2004, 112:1725-1733.
37. Nordberg A., Rudén C. The usefulness of the bioconcentration factor as a tool for priority setting in chemicals control. Toxicol Lett 2007, 168:113-120.
38. OECD, Organization for Economic Cooperation and Development Guidelines for the testing of chemicals. Section2: Effects on Biotic Systems TG- No. 210: Fish, Early-Life Stage Toxicity Test 1992, Organization for Economic Co-operation and Development, Paris, France.
39. OECD, Organization for Economic Cooperation and Development Guidelines for the testing of chemicals. Section2: Effects on Biotic Systems TG- No. 305: Bioconcentration: Flow-through Fish Test 1996, Organization for Economic Co-operation and Development, Paris, France.
40. OECD, Organization for Economic Cooperation and Development Guidelines for the testing of chemicals. TG No. 212. Fish, short-term toxicity test on embryo and sac-fry stages 1998, Organization for Economic Co-operation and Development, Paris, France.
41. OECD, Organization for Economic Cooperation and Development Harmonized integrated hazard classification system for human health and environmental hazards of chemical substances and mixtures. Annex 2. Guidance Document 27, ENV/JM/MONO (2001) 2001, [8], Organization for Economic Co-operation and Development, Paris, France.
42. OECD, Organization for Economic Cooperation and Development Guidelines for the testing of chemicals. The amphibian metamorphosis assay 2009, [TG No. 231], Organization for Economic Co-operation and Development, Paris, France.
43. Overturf M.D., Overturf C.L., Baxter D., Hala D.N., Constantine L., Venables B., et al. Early life-stage toxicity of eight pharmaceuticals to the Fathead Minnow, Pimephales promelas. Arch Environ Contam Toxicol 2011, 62:455-464.
44. Pahor M., Guralnik J.M., Furberg C.D., Carbonin P., Havlik R.J. Risk of gastrointestinal haemorrhage with calcium antagonists in hypertensive persons over 67years old. Lancet 1996, 347:1061-1065.
45. Paterson G., Metcalfe C.D. Uptake and depuration of the anti-depressant fluoxetine by the Japanese medaka (Oryzias latipes). Chemosphere 2008, 74:125-130.
46. Penaz M., Prokes M., Kouril J., Hamackova J. Early development of the carp Cyprinus carpio. Acta Sci Nat Brno 1983, 17:1-39.
47. Ramirez A.J., Brain R.A., Usenko S., Mottaleb M.A., O'Donnell J.G., Stahl L.L., et al. Occurrence of pharmaceuticals and personal care products in fish: results of a national pilot study in the United States. Environ Toxicol Chem 2009, 28:2587-2597.
48. Regenthal R., Krueger M., Koeppel C., Preiss R. Drug levels: Therapeutic and toxic serum/plasma concentrations of common drugs. J ClinMonit 1999, 15:529-544.
49. Reder-Hilz B., Ullrich M., Ringel M., Hewitt N., Utesch D., Oesch F., et al. Metabolism of propafenone and verapamil by cryopreserved human, rat. mouse and dog hepatocytes: comparison with metabolism in vivo. Naunyn Schmiedebergs Arch Pharmacol 2004, 369:408-417.
50. The toxicology of fishes 2008, 4. CRC Press, New York. T. Richard, D. Giulio, D.E. Hinton (Eds.).
51. Rottbauer W., Baker K., Wo Z.G., Mohideen M.-A.P.K., Cantiello H.F., Fishman M.C. Growth and function of the embryonic heart depend upon the cardiac-specific L-type calcium channel [alpha]1 subunit. Dev Cell 2001, 1:265-275.
52. Schulz M., Schmoldt A. Therapeutic and toxic blood concentrations of more than 800 drugs and other xenobiotics. Pharmazie 2003, 58:447-474.
53. Shin J.T., Pomerantsev E.V., Mably J.D., MacRae C.A. High-resolution cardiovascular function confirms functional orthology of myocardial contractility pathways in zebrafish. Physiol Genomics 2010, 42:300-309.
54. Springer T.A., Guiney P.D., Krueger H.O., Jaber M.J. Assessment of an approach to estimate aquatic bioconcentration factor using reduced sampling. Environ Toxicol Chem 2008, 27:2271-2280.
55. Sudova E., Machova J., Svobodova Z., Vesely T. Negative effects of malachite green and possibilities of its replacement in the treatment of fish eggs and fish: a review. Vet Med Praha 2007, 52:527-539527.
56. US EPA Estimation Programs Interface Suite™ for Microsoft® Windows, v 4.11. United States Environmental Protection Agency, Washington, DC, USA http://www.epa.gov/opptintr/exposure/pubs/episuite.htm.
57. Villegas-Navarro A., Rosas-L E., Reyes J.L. The heart of Daphnia magna: effects of four cardioactive drugs. Comp Biochem Physiol C: Toxicol Pharmacol 2003, 136:127-134.
58. Wood A.J.J., Abernethy D.R., Schwartz J.B. Calcium-antagonist drugs. N Eng J Med 1999, 341:1447-1457.